Shanghai Biostatistics Forum (SBF) 3rd Event, 2012---2012.10.16

http://stat.smmu.edu.cn/upfiles/201210968696.doc
8 R* S( v; k! w( f( [9 G
Shanghai Biostatistics Forum (SBF) 3rd Event 2012 |Oct 16, 2012 Tuesday, 2pm-5:30pm |Second Military Medical University (SMMU)
% d5 b2 n3 ^2 M1 M) n/ H% Q

Theme:
- X; q# K3 `* m5 ?8 f2 G+ l* hPersonalized Medicine in Oncology Clinical Trials
Agenda (2-5:30pm):

6 i% l* I1 c- b( r§         Opening
/ D) ?6 U( s" v; X3 |; k( _+ ]* LDr. Jacqueline Law (Roche) and Prof. Jia He (SMMU)
* P  s. s' C2 o3 u
2 w" A2 [* [' L- m3 f" j4 S0 H  c2 x§         OPTIMAL: Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer 研究背后故事及结果解读
Speaker: Dr.  周彩存 (教授, 主任医师, 上海肺科医院)

§         BATTLE: A Clinical Trial Design Applying Bayesian Adaptive Randomization for Targeted Therapy Development in Lung Cancer- A Step Toward Personalized Medicine
/ n* D+ S) b5 L9 E) w' R" X) K. gSpeaker: Dr. Xian Zhou (Associate Director, Biostatistics, Roche)
0 a5 _# b# p0 W" p( \# C, V
; V1 [$ W7 j% ?5 H6 {' _+ v§         Development of Herceptin and its diagnostics: a story on the success of personalized medicine
Speaker: Dr. Jacqueline Law (AP Biostatistics Site Head, Director, Roche)

§         Closing